Imiquimod bulk supplier for pharma manufacturers

Imiquimod 3.75%, 2.5%, 5% Suppliers & Bulk Manufacturers

Available Forms: Creams

Available Strengths: 3.75%, 2.5%, 5%

Reference Brands: Aldara (USA), Zyclara (USA)

Imiquimod is a topical immune response modifier used for the treatment of various skin conditions, including actinic keratosis, superficial basal cell carcinoma, and external genital or perianal warts. It works by stimulating the local immune system, promoting the production of cytokines that help the body fight abnormal or virus-infected cells. Imiquimod is available in cream formulations and is applied directly to the affected skin area, offering a non-invasive treatment option for dermatological conditions.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Imiquimod? List it or send an offer →

Product Description:

Imiquimod does not kill abnormal cells directly. It is an immune response modifier that binds toll-like receptor 7 on dendritic cells and macrophages, triggering release of interferon-alpha, tumour necrosis factor and interleukins, which recruit a local cell-mediated immune response against virally infected or dysplastic cells. The inflammation it provokes is the treatment, not a side effect.

It is used for external genital and perianal warts, actinic keratoses, and superficial basal cell carcinoma where surgery is unsuitable, with different strengths and schedules for each. Patients must understand what to expect: marked redness, erosion, crusting and discomfort at the treated site are normal and correlate with response, but they can be severe, and rest periods are built into the regimens. Systemic flu-like symptoms occur. Treated skin should not be occluded, and sun exposure is avoided.

Sourcing notes. Off patent, with generics widely available. The strengths correspond to different indications and regimens and are not interchangeable, so a quotation must state which. Single-use sachets are standard for the genital wart and actinic keratosis regimens, and sachet count per pack is what determines whether a pack covers a full course.

Imiquimod — third party manufacturing & bulk supply

Imiquimod 3.75%, 2.5%, 5% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Imiquimod is supplied as Creams — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Imiquimod listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Imiquimod →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Imiquimod is listed as Creams in 3.75%, 2.5%, 5%. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Imiquimod is referenced against Aldara (USA), Zyclara (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.